TSS
XERS icon

Two Sigma Securities’s Xeris Biopharma Holdings XERS Stock Holding History

Two Sigma Securities’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,900
Closed -$29K – 3740
2024
Q2 		$29K Buy
+12,900
New +$26K ﹤0.01% 2644
2024
Q1 		– Sell
-16,864
Closed -$39.6K – 3741
2023
Q4 		$39.6K Buy
+16,864
New +$31.1K ﹤0.01% 2634
2023
Q1 		– Sell
-61,470
Closed -$81.8K – 3366
2022
Q4 		$81.8K Buy
+61,470
New +$86.8K ﹤0.01% 2097

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Two Sigma Securities's XERS Position: Q3 2024 in Review

Two Sigma Securities sold out of Xeris Biopharma Holdings (XERS) in Q3 2024, closing a stake of 12,900 shares — an estimated $29K sold.

Two Sigma Securities first reported a position in XERS in Q4 2022 and held it in 3 quarters. The position peaked at $81.8K in Q4 2022. 144 funds tracked by Wall St. Rank hold XERS as of Q3 2024.

  • Two Sigma Securities reported no remaining Xeris Biopharma Holdings position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 12,900 Xeris Biopharma Holdings shares in Q3 2024, an estimated $29K.
  • Two Sigma Securities first reported a position in Xeris Biopharma Holdings in Q4 2022 and held it in 3 quarters.
  • Two Sigma Securities's Xeris Biopharma Holdings position peaked at $81.8K in Q4 2022.
  • 144 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.